rewirebio.iobenchmarks
Configuration

VarSome vs. CanVIG-UK three-category concordance comparison

Three-category classification (PV/LPV, VUS, BV/LBV) compared between VarSome and the BRCA1/BRCA2 CanVIG-UK gene-specific guidance on the same conflicting-variant cohort.

1 evaluation · 2 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for VarSome vs. CanVIG-UK three-category concordance comparison. Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluations and results

1 evaluation · 2 results. Different protocols are not a single leaderboard.

Protocol: So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants · Dataset: So 2024 BRCA1 conflicting-classification missense cohort

Sorted by Percent agreement (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationPercent agreementCount (concordant classifications)
VarSome vs. CanVIG-UK three-category concordance comparisonEvaluation58.9%265
All 2 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: VarSome vs. CanVIG-UK three-category concordance comparisonProtocol: So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants
Dataset: So 2024 BRCA1 conflicting-classification missense cohort
58.9% Percent agreement
percent · higher

Uncertainty: 95% CI 52.0 to 66.4

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

So 2024 VarSome-vs-CanVIG-UK agreement evaluation

Not reported

Aggregation: Not reported

Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance · Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK": "The overall concordance rate was 58.9% (95% CI: 52.0-66.4%; 265/450) between VarSome and CanVIG-UK (Figure 2)."
Configuration: VarSome vs. CanVIG-UK three-category concordance comparisonProtocol: So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants
Dataset: So 2024 BRCA1 conflicting-classification missense cohort
265 Count (concordant classifications)
count · unknown

Uncertainty: Not applicable: reported at the rate level only; see concordance_rate result

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

So 2024 VarSome-vs-CanVIG-UK agreement evaluation

Not reported

Aggregation: Not reported

Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance · Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK": "The overall concordance rate was 58.9% (95% CI: 52.0-66.4%; 265/450) between VarSome and CanVIG-UK (Figure 2)."

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Use this configuration

How it works, versions and access

Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20261005-so-2024-varsome-canvig-config.

Related records

How to cite

VarSome vs. CanVIG-UK three-category concordance comparison. Rewire biological model benchmark database, release 2026-11-21-adc15377fab2. https://benchmarks.rewirebio.io/database/configuration/uc-clinical-20261005-so-2024-varsome-canvig-config/

Release 2026-11-21-adc15377fab2. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction